Eisai
4523.T
#2073
Rank
A$12.19 B
Marketcap
$43.27
Share price
-0.33%
Change (1 day)
-39.71%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): $3.26

According to Eisai's latest financial reports the company's current EPS (TTM) is $3.48. In 2022 the company made an earnings per share (EPS) of $2.56 a decrease over its 2021 EPS that were of $11.34.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$3.2627.54%
2022$2.56-77.48%
2021$11.34-41.88%
2020$19.52-0.94%
2019$19.7052.59%
2018$12.91124.17%
2017$5.76-49.42%
2016$11.3937.08%
2015$8.31-11.75%
2014$9.41-3.23%
2013$9.73-18.56%
2012$11.95-15.51%
2011$14.14-3.75%
2010$14.69-1.36%
2009$14.89